Get started
Author

Ann Marie DiRaddo

Observed name: Ann Marie Diraddo
OpenAlex ID: A5040608403
Appearance-Based Rejection Sensitivity Predicts Body Dysmorphic Disorder Symptoms and Cosmetic Surgery Acceptance
2010 · Lora E. Park, Rachel M. Calogero, et al. · Journal of Social and Clinical Psychology · 118
Predicting interest in cosmetic surgery: Interactive effects of appearance-based rejection sensitivity and negative appearance comments
2009 · Lora E. Park, Rachel M. Calogero, et al. · Body Image · 101
Sociocultural Influence and Appearance-Based Rejection Sensitivity Among College Students
2009 · Lora E. Park, Ann Marie DiRaddo, et al. · Psychology of Women Quarterly · 62
Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events
2017 · Sidra Anwar, Wei Tan, et al. · Cancers · 11
PDF
A pharmacokinetic and dose-escalating study of paclitaxel injection concentrate for nano-dispersion (PICN) alone and with carboplatin in patients with advanced solid tumors.
2013 · Wen Wee Ma, Elaine Tat Lam, et al. · Journal of Clinical Oncology · 4
A phase I/II trial of pazopanib alternating with bevacizumab in treatment-naïve metastatic clear cell renal cell carcinoma (CCRCC) patients: Phase I results.
2019 · Saby George, Laurie Herbst, et al. · Journal of Clinical Oncology · 3
Evaluation of Quality-of-life (QoL) in patients(pts) with advanced solid tumors as screening tool during phase 1 clinical trial recruitment- risk assessment for adverse events and subject replacement.
2015 · Sidra Anwar, Wei Tan, et al. · Journal of Clinical Oncology · 2
A phase I and pharmacokinetic study of a weekly dosing schedule of paclitaxel injection concentrate for nano-dispersion (PICN) in patients with advanced solid tumors.
2014 · Wen Wee Ma, Jennifer Robinson Diamond, et al. · Journal of Clinical Oncology · 1
Works count: 8
Citation count: 302
H-index: 4
I10-index: 4
Year
Topic
Type